Pharmaceutical Price Controls and Minimum Efficacy Regulation: Evidence from the United States and Italy

摘要

ObjectiveThis article examines the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: minimum efficacy standards (MES) and a mix of MES and price control mechanisms (MES + PC).